Pasar al contenido principal

PAPEL DE LA SEÑALIZACION MEDIADA POR TGFB EN LAS ADAPTACIONES METABOLICAS MATERNAS DURANTE EL EMBARAZO: IMPLICACIONES PARA EL DESARROLLO DE LA DIABETES MELLITUS GESTACIONAL.

PID2020-113112RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD MIGUEL HERNANDEZ DE ELCHE

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

RUA. Repositorio Institucional de la Universidad de Alicante
Publicación Otros (Other)

Increased TGF-β/Activin-Smad2 signaling is associated with pancreatic β-cell dysfunction and glucose intolerance in gestational diabetes mellitus

  • Boronat-Belda, Talía
  • Ferrero, Hilda
  • Soriano, Sergi
  • Ribes-García, Elena
  • Betoret-Gustems, Rubén
  • Martínez-Bañón, Daniel
  • Serrano-Selva, Mónica
  • Martinez-Pinna, Juan
  • Nadal, Ángel
  • Quesada, Iván
  • Alonso Magdalena, Paloma
  • Ferrero, Hilda|||/items/b14c3b70-6622-414b-85e8-332ff8cd0de7
  • Soriano, Sergi|||/items/8e3d590c-5b30-415a-93aa-bf5d4506efe4
  • Martinez-Pinna, Juan|||/items/17fe7946-bb18-45cf-bd71-482acc1cec7b
Background: Gestational diabetes mellitus (GDM) is the most common metabolic disease during pregnancy and increases the prevalence of type 2 diabetes in both mothers and children. GDM management provides an opportunity to prevent and lower the global burden of diabetes across life. Molecular mechanisms underlying GDM are not completely understood. In this study, we explore the role of transforming growth factor beta (TGF-β) signaling in GDM, as this pathway reportedly affects pancreatic β-cell development, function, and proliferation. Methods: We developed a GDM animal model. Serum circulating levels of TGF-β family ligands were measured in mice and human GDM. Pancreatic TGF-β signaling was investigated via gene and protein expression. Results: Our GDM animal model recapitulates the main pathophysiological features of human GDM, including glucose intolerance, decreased insulin sensitivity and pancreatic β-cell malfunction. Islets from GDM mice showed impaired insulin secretion and content, altered ion channel activity, and decreased β-cell replication rate. This was accompanied by increased Smad2 signaling activation. Elevated serum activin-A and inhibin levels were found in mice and human GDM, suggesting their role as upstream signaling transducers of pancreatic Smad2 activation. Pharmacological inhibition of TGF-β/Activin-Smad2 signaling in mouse pancreatic islets resulted in improved pancreatic β-cell function and regeneration capacity. Conclusions: Our data suggest that disruption of the pancreatic Smad2 pathway plays a critical role in the pathogenesis of GDM, contributing to abnormal glucose homeostasis and inadequate insulin secretion. Attenuation of this signaling pathway may represent a putative therapeutic target for GDM.
RUA. Repositorio Institucional de la Universidad de Alicante
Publicación Otros (Other)

Screening of Relevant Metabolism-Disrupting Chemicals on Pancreatic β-Cells: Evaluation of Murine and Human In Vitro Models

  • Al-Abdulla, Ruba
  • Ferrero, Hilda
  • Soriano, Sergi
  • Boronat-Belda, Talía
  • Alonso Magdalena, Paloma
  • Ferrero, Hilda|||/items/b14c3b70-6622-414b-85e8-332ff8cd0de7
  • Soriano, Sergi|||/items/8e3d590c-5b30-415a-93aa-bf5d4506efe4
Endocrine-disrupting chemicals (EDCs) are chemical substances that can interfere with the normal function of the endocrine system. EDCs are ubiquitous and can be found in a variety of consumer products such as food packaging materials, personal care and household products, plastic additives, and flame retardants. Over the last decade, the impact of EDCs on human health has been widely acknowledged as they have been associated with different endocrine diseases. Among them, a subset called metabolism-disrupting chemicals (MDCs) is able to promote metabolic changes that can lead to the development of metabolic disorders such as diabetes, obesity, hepatic steatosis, and metabolic syndrome, among others. Despite this, today, there are still no definitive and standardized in vitro tools to support the metabolic risk assessment of existing and emerging MDCs for regulatory purposes. Here, we evaluated the following two different pancreatic cell-based in vitro systems: the murine pancreatic β-cell line MIN6 as well as the human pancreatic β-cell line EndoC-βH1. Both were challenged with the following range of relevant concentrations of seven well-known EDCs: (bisphenol-A (BPA), bisphenol-S (BPS), bisphenol-F (BPF), perfluorooctanesulfonic acid (PFOS), di(2-ethylhexyl) phthalate (DEHP), cadmium chloride (CdCl2), and dichlorodiphenyldichloroethylene (DDE)). The screening revealed that most of the tested chemicals have detectable, deleterious effects on glucose-stimulated insulin release, insulin content, electrical activity, gene expression, and/or viability. Our data provide new molecular information on the direct effects of the selected chemicals on key aspects of pancreatic β-cell function, such as the stimulus-secretion coupling and ion channel activity. In addition, we found that, in general, the sensitivity and responses were comparable to those from other in vivo studies reported in the literature. Overall, our results suggest that both systems can serve as effective tools for the rapid screening of potential MDC effects on pancreatic β-cell physiology as well as for deciphering and better understanding the molecular mechanisms that underlie their action.
RUA. Repositorio Institucional de la Universidad de Alicante
Publicación Otros (Other)

The pancreatic β-cell in ageing: Implications in age-related diabetes

  • Tudurí, Eva
  • Soriano, Sergi
  • Almagro, Lucía
  • Montanya, Eduard
  • Alonso Magdalena, Paloma
  • Nadal, Ángel
  • Quesada, Iván
  • Soriano, Sergi|||/items/8e3d590c-5b30-415a-93aa-bf5d4506efe4
  • Tudurí, Eva|||/items/ed03c763-6d0f-4b5a-a720-80238ac8cc4e
The prevalence of type 2 diabetes (T2D) and impaired glucose tolerance (IGT) increases with ageing. T2D generally results from progressive impairment of the pancreatic islets to adapt β-cell mass and function in the setting of insulin resistance and increased insulin demand. Several studies have shown an age-related decline in peripheral insulin sensitivity. However, a precise understanding of the pancreatic β-cell response in ageing is still lacking. In this review, we summarize the age-related alterations, adaptations and/or failures of β-cells at the molecular, morphological and functional levels in mouse and human. Age-associated alterations include processes such as β-cell proliferation, apoptosis and cell identity that can influence β-cell mass. Age-related changes also affect β-cell function at distinct steps including electrical activity, Ca2+ signaling and insulin secretion, among others. We will consider the potential impact of these alterations and those mediated by senescence pathways on β-cells and their implications in age-related T2D. Finally, given the great diversity of results in the field of β-cell ageing, we will discuss the sources of this heterogeneity. A better understanding of β-cell biology during ageing, particularly at older ages, will improve our insight into the contribution of β-cells to age-associated T2D and may boost new therapeutic strategies.
RUA. Repositorio Institucional de la Universidad de Alicante
Publicación Otros (Other)

Aging Affects Pancreatic α-Cell Function and Promotes Hyperglucagonemia: Implications in Age-Associated Diabetes

  • Tudurí, Eva|||/items/ed03c763-6d0f-4b5a-a720-80238ac8cc4e
  • Almagro, Lucía
  • Ojeda-Rodríguez, Ana
  • Pascua-Maestro, Raquel
  • Brunetta, Henver S.
  • Soriano, Sergi|||/items/8e3d590c-5b30-415a-93aa-bf5d4506efe4
  • López-Moreno, Alejandro
  • Boronat-Belda, Talía
  • Velasco-Avilés, Sergio
  • da Silva Junior, Joel Alves
  • Castellano-Muñoz, Manuel
  • Rafacho, Alex
  • Cozar-Castellano, Irene
  • Nadal, Ángel
  • Alonso Magdalena, Paloma
  • Merino, Beatriz
  • Lopez-Miranda, Jose
  • Quesada, Iván
Aging is a major risk factor in the development of type 2 diabetes mellitus (T2DM). With age, pancreatic β-cells undergo functional and cell identity changes that can compromise insulin secretion, thereby contributing to impaired glucose tolerance and T2DM. However, glucose homeostasis also depends on pancreatic α-cells. Excessive plasma glucagon levels, along with impaired regulation of α-cell secretion, are involved in the pathophysiology of T2DM. Despite their importance, the effects of aging on α-cells have been overlooked. In the present study, we analyzed pancreatic α-cells in aged mice with normal insulin sensitivity and in those with peripheral insulin resistance. Regardless of insulin sensitivity, aged mice exhibited hyperglucagonemia and increased glucagon release. Ex vivo, these alterations were associated with increased α-cell mass, higher glucagon content, impaired suppression of glucagon secretion, and endoplasmic reticulum stress. Furthermore, aged mice showed remodeling of islet cellular composition and changes in the spatial organization of α-cells within the islet. Additionally, moderate alterations in α-cell identity were noted. While most of these alterations were already present in aged mice with normal insulin sensitivity, they were generally more pronounced with insulin resistance. Examination of the CORDIOPREV clinical study revealed the presence of hyperglucagonemia in older adults with insulin resistance. Additionally, an increased risk of developing T2DM was also found in older people with higher plasma glucagon levels. The findings described here indicate that aging affects the biology of α-cells and glucagon, positioning them as active players in impaired glucose tolerance and diabetes associated with aging.
RUA. Repositorio Institucional de la Universidad de Alicante
Publicación Otros (Other)

Inhibition of glucagon secretion from pancreatic α-cells by the bile acid TUDCA involves a S1PR2-PI3K pathway

  • da Silva Junior, Joel Alves
  • Vettorazzi, Jean Franciesco
  • Soriano, Sergi
  • Bru-Tarí, Eva
  • Boronat-Belda, Talía
  • Castellano-Muñoz, Manuel
  • Borck, Patricia Cristine
  • Ribeiro, Rosane Aparecida
  • Soares, Gabriela Moreira
  • Lubaczeuski, Camila
  • Boschero, Antônio Carlos
  • Marroquí, Laura
  • Nadal, Ángel
  • Alonso Magdalena, Paloma
  • Quesada, Iván
  • Carneiro, Everardo Magalhães
  • Soriano, Sergi|||/items/8e3d590c-5b30-415a-93aa-bf5d4506efe4
The global prevalence of type 2 diabetes (T2D) continues to rise, and predictions indicate alarming records in coming decades. Although pancreatic β-cell dysfunction and insulin resistance are key factors in the etiology of T2D, the impairment of α-cells has been also implicated. Hyperglucagonemia and altered suppression of glucagon release can be frequently found in individuals with T2D, contributing to hyperglycemia. Bile acids have emerged as novel signaling molecules that regulate metabolism. A wealth of evidence shows that oral treatment with the bile acid TUDCA has therapeutic benefits in T2D, primarily by improving both insulin release from β-cells and insulin sensitivity in peripheral tissues. However, it is unknown whether TUDCA could affect other processes involved in the control of glucose metabolism. Here, we show that acute administration of TUDCA exerts a glucagonstatic action on mouse pancreatic islets and glucagon-releasing αTC1-9 cells. Pharmacological and/or molecular inhibition of the sphingosine-1-phosphate receptor 2 (S1PR2) and the PI3K pathway blunted the TUDCA effect on glucagon release. Additionally, TUDCA increased the activity of ATP-sensitive K+ (KATP) channels, decreased action currents and inhibited Ca2+ signaling in α-cells without directly affecting the exocytotic process. Glucose-induced suppression of glucagon secretion was found to be compromised under hyperglycemic conditions, yet TUDCA was able to inhibit α-cell function, highlighting its glucagonstatic effect in a pathological context. Collectively, these findings suggest that TUDCA-induced inhibition of glucagon secretion involves the opening of α-cell KATP channels and activation of the S1PR2/PI3K pathway, expanding the repertoire of potential therapeutic benefits of TUDCA in diabetes treatment.
RUA. Repositorio Institucional de la Universidad de Alicante
Publicación Otros (Other)

Exploring the Effects of Metabolism-Disrupting Chemicals on Pancreatic α-Cell Viability, Gene Expression and Function: A Screening Testing Approach

  • Al-Abdulla, Ruba
  • Ferrero, Hilda
  • Boronat-Belda, Talía
  • Soriano, Sergi
  • Quesada, Iván
  • Alonso Magdalena, Paloma
  • Ferrero, Hilda|||/items/b14c3b70-6622-414b-85e8-332ff8cd0de7
  • Soriano, Sergi|||/items/8e3d590c-5b30-415a-93aa-bf5d4506efe4
Humans are constantly exposed to many environmental pollutants, some of which have been largely acknowledged as key factors in the development of metabolic disorders such as diabetes and obesity. These chemicals have been classified as endocrine-disrupting chemicals (EDCs) and, more recently, since they can interfere with metabolic functions, they have been renamed as metabolism-disrupting chemicals (MDCs). MDCs are present in many consumer products, including food packaging, personal care products, plastic bottles and containers, and detergents. The scientific literature has ever-increasingly focused on insulin-releasing pancreatic β-cells as one of the main targets for MDCs. Evidence highlights that these substances may disrupt glucose homeostasis by altering pancreatic β-cell physiology. However, their potential impact on glucagon-secreting pancreatic α-cells remains poorly known despite the essential role that this cellular type plays in controlling glucose metabolism. In the present study, we have selected seven paradigmatic MDCs representing major toxic classes, including bisphenols, phthalates, perfluorinated compounds, metals, and pesticides. By using an in vitro cell-based model, the pancreatic α-cell line αTC1-9, we have explored the effects of these compounds on pancreatic α-cell viability, gene expression, and secretion. We found that cell viability was moderately affected after bisphenol-A (BPA), bisphenol-F (BPF), and perfluorooctanesulfonic acid (PFOS) exposure, although cytotoxicity was relatively low. In addition, all bisphenols, as well as di(2-ethylhexyl) phthalate (DEHP) and cadmium chloride (CdCl2), promoted a marked decreased on glucagon secretion, together with changes in the expression of glucagon and/or transcription factors involved in cell function and identity, such as Foxo1 and Arx. Overall, our results indicated that most of the selected chemicals studied caused functional alterations in pancreatic α-cells. Moreover, we revealed, for the first time, their direct effects on key molecular aspects of pancreatic α-cell biology.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Hyperglucagonemia and glucagon hypersecretion in early type 2 diabetes result from multifaceted dysregulation of pancreatic mouse α-cells

  • Ruiz-Pino, Antonia
  • Goncalves-Ramírez, Arianna
  • Jiménez-Palomares, Margarita
  • Merino, Beatriz
  • Castellano-Muñoz, Manuel
  • Vettorazzi, Jean F
  • Rafacho, Alex
  • Marroquí, Laura
  • Nadal, Ángel
  • Alonso-Magdalena, Paloma
  • Perdomo, Germán
  • Cózar-Castellano, Irene
  • Quesada, Iván
Hyperglucagonemia has been implicated in the pathogenesis of type 2 diabetes (T2D). In contrast to β-cells, studies on the function of the pancreatic α-cell in T2D are scarce. Consequently, the processes underlying hyperglucagonemia and α-cell dysfunction are largely unknown, limiting the appropriate design of specific pharmacological and therapeutic strategies. In the current study, we aimed to analyze the alterations of the pancreatic α-cell and its glucagon responses in diabetic db/db mice at early stages of the disease. In this context of glucose intolerance, hyperinsulinemia, and β-cell dysfunction, hyperglucagonemia was only present at fed conditions and was associated with insulin resistance. Yet, we found that the glucagon-to-insulin ratio in db/db mice did not change with fed or fasted states, further supporting that the metabolic regulation of glucagon release was impaired. Pancreatic β-cell dysfunction in db/db mice was manifested by increased basal secretion from isolated islets along with reduced insulin content. In contrast, α-cells from diabetic animals presented upregulated secretion and islet content of glucagon compared with controls. Electrophysiological analysis of dispersed α-cells revealed that altered secretion was not the result of impaired exocytosis. Instead, we found defective regulation of Ca2+ signaling by glucose. Besides these functional alterations, we also observed augmented α-cell mass in diabetic mice, which was accompanied by disrupted islet cytoarchitecture as well as increased α-cell size and number, without pieces of evidence of upregulated proliferation. Overall, these findings indicate that hyperglucagonemia in early T2D results from multifaceted α-cell deregulation in mice., This work was supported by grants from the Agencia Estatal de Investigación (PID2020-113112RB-I00, PID2020-117569RA-I00, PID2020-117294RB-I00, PID2022-136605OB-C21), and Generalitat Valenciana (PROMETEO/2020/006). CIBERDEM is an initiative of the Instituto de Salud Carlos III., Peer reviewed